Ensysce Biosciences, INC. (ENSC) — SEC Filings
Latest SEC filings for Ensysce Biosciences, INC.. Recent EFFECT filing on Apr 16, 2026. AI-decoded analysis of earnings, risk factors, and insider trades.
View Ensysce Biosciences, INC. on SEC EDGAR
Overview
Ensysce Biosciences, INC. (ENSC) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a EFFECT filed on Apr 16, 2026: Ensysce Biosciences, Inc. filed an EFFECT form on April 16, 2026, indicating the effectiveness of a registration statement. The effectiveness date is April 15, 2026, related to file number 333-294939.
Sentiment Summary
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant filing sentiment for Ensysce Biosciences, INC. is neutral.
Filing Type Overview
Ensysce Biosciences, INC. (ENSC) has filed 1 EFFECT with the SEC between Apr 2026.
Recent Filings (1)
-
Ensysce Biosciences Effectiveness Notice Filed
— EFFECT · Apr 16, 2026 Risk: medium
Ensysce Biosciences, Inc. filed an EFFECT form on April 16, 2026, indicating the effectiveness of a registration statement. The effectiveness date is April 15,
Related Companies
Frequently Asked Questions
What are the latest SEC filings for Ensysce Biosciences, INC. (ENSC)?
Ensysce Biosciences, INC. has 1 recent SEC filings from Apr 2026, including 1 EFFECT. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of ENSC filings?
Across 1 filings, the sentiment breakdown is: 1 neutral. The dominant sentiment is neutral.
Where can I find Ensysce Biosciences, INC. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Ensysce Biosciences, INC. (ENSC) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.